Claret Capital Partners Closes Fourth Fund at €575 Million for European Growth Debt

The fund attracted commitments from institutional investors, including pension plans, insurers, family offices and other public and institutional investors, as well as private wealth investors through an ELTIF structure. It will also draw on a series of discretionary co-investment partnerships to support larger deals.

Tech.eu reported that the fund has already deployed 32 percent of its capital, backing more than 27 companies. These include the B2B buy-now-pay-later platform Billie, clinical-stage pharmaceutical company Cinclus Pharma, commercial real estate software provider PRODA, biotech firm Inventiva and sales intelligence platform Surfe. Claret provides lower-dilution financing to companies pursuing international expansion, acquisitions and product development. The close follows Claret's previous fund, which raised €297 million.

David Bateman, Managing Partner at Claret Capital Partners, said the amount raised validated the firm's approach and track record and represented a vote of confidence in the European technology, life sciences and impact ecosystems. He added that, with a growing pipeline of opportunities, the team is actively deploying capital and continuing to seek entrepreneurs building the next generation of European champions.

Tether's USDT still leads on global supply, but EU compliance rules under MiCA are reshaping where each stablecoin can operate.